Austin Moldow Initiated (UTI) at Strong Buy and Held Target at $12 on, Sep 17th, 2020
Austin has made no other calls on UTI in the last 4 months.
There is 1 other peer that has a rating on UTI. Out of the 1 peers that are also analyzing UTI, 0 agree with Austin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Austin
- David Coleman of "Argus Research" Maintained at Strong Buy with Decreased Target to $9 on, Tuesday, June 2nd, 2020
Like: 👍
on: Wed, Feb 12th 2020
by: WOPRAI
Raj Sharma Maintained (UTI) at Strong Buy with Increased Target to $11 on, Feb 12th, 2020
on: Tue, Feb 11th 2020
by: WOPRAI
David Coleman Upgraded (UTI) to Strong Buy and Held Target at $12 on, Feb 11th, 2020
on: Mon, Jul 30th 2018
by: WOPRAI
Kyle Rose Maintained (ZBH) at Hold with Increased Target to $125 on, Jul 30th, 2018
on: Fri, Jul 17th 2020
by: WOPRAI
Garrett Nelson Downgraded (TSLA) to Strong Sell on, Jul 17th, 2020
on: Fri, Jul 17th 2020
by: WOPRAI
Ben Kallo Maintained (TSLA) at Hold and Held Target at $984 on, Jul 17th, 2020
on: Fri, Jul 17th 2020
by: WOPRAI
Dan Levy Maintained (TSLA) at Hold with Increased Target to $19 on, Jul 17th, 2020
on: Tue, Jun 02nd 2020
by: WOPRAI
David Coleman Maintained (UTI) at Strong Buy with Decreased Target to $9 on, Jun 2nd, 2020
on: Thu, Sep 28th 2017
by: WOPRAI
on: Wed, Sep 16th 2020
by: WOPRAI
Laura Martin Maintained (AAPL) at Strong Buy with Increased Target to $140 on, Sep 16th, 2020
on: Thu, Sep 10th 2020
by: WOPRAI
William Power Maintained (AAPL) at Buy with Increased Target to $133 on, Sep 10th, 2020
on: Wed, Sep 09th 2020
by: WOPRAI
Kristine Liwag Initiated (SPR) at Sell and Held Target at $18 on, Sep 9th, 2020
on: Tue, Sep 01st 2020
by: WOPRAI
Jeriel Ong Maintained (AAPL) at Strong Buy with Decreased Target to $140 on, Sep 1st, 2020
